Brief: Senores Pharmaceuticals Invests $2 Million Through Rights Issue In US Unit
18/09/2025 11:29
Sept 18 (Reuters) - Senores Pharmaceuticals Ltd SENO.NS: SENORES PHARMACEUTICALS - INVESTMENT OF $2 MILLION THROUGH RIGHTS ISSUE IN US UNIT Source text: ID:nBSEfyK55 Further company coverage: SENO.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Senores Pharmaceuticals
See all newsBrief: Senores Pharmaceuticals Approves Re-Appointment Of Swapnil Jatinbhai Shah As Managing Director
Brief: Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility
Brief: Senores Pharmaceuticals Says To Incorporate Units In Mexico, Canada
Brief: Senores Pharmaceuticals Ltd June-Quarter Consol Net Profit 307.2 Million Rupees
Brief: Senores Pharmaceuticals March-Quarter Consol Net Profit 316.1 Million Rupees